… treatment failure compared with erlotinib (HR 0.62; … erlotinib exerted significant benefits in
PFS compared to gefitinib. As expected, in this study, the administration of afatinib and erlotinib …

… efficacy 16 and the observed overlap in PK parameters between patients without rash and
those with any grade of rash 9 suggest that erlotinib … documented the efficacy of erlotinib in …

… explored the efficacy and safety of VEGF neutralizing antibodies, combined with erlotinib. …
was to explore the efficacy and safety of combined medications, and simultaneously to conduct …

… The purpose of this study was to evaluate the efficacy and … carcinoma, indicating that the
efficacy of anlotinib in improving PFS … We also compared the efficacy of anlotinib and anlotinib …

… use with prescription drug(s) resulted in erlotinib or gefitinib discontinuation. There were no
significant DDIs determined between erlotinib … on the therapeutic efficacy of erlotinib, gefitinib…

… The EVAN study investigated the efficacy and safety of erlotinib versus vinorelbine/cisplatin
as adjuvant chemotherapy after R0 in patients with stage IIIA NSCLC and epidermal growth …

… Our study found erlotinib was dominated by afatinib and gefitinib, while afatinib was the
most cost-effective option with incremental cost-effectiveness ratio estimates of $34,879 per life-…

… of 160 patients were randomized to erlotinib plus bevacizumab (80) or erlotinib alone (80).
At a … [CI]: 12.2–18.6) with erlotinib plus bevacizumab and 9.6 months (95% CI: 8.2–10.6) with …

… From these data, one can speculate that if the price of erlotinib was reduced or erlotinib
efficacy was increased in the patients with pancreatic cancer, the ICER would produce a greater …

… In the FLAURA trial, first-line treatment with osimertinib demonstrated superior efficacy to
erlotinib or gefitinib in patients with EGFRm advanced NSCLC, including in patients with CNS …